Theravance Biopharma (TBPH) PT Lowered to $10 at BofA Securities
Tweet
Share
E-mailGet Alerts TBPH Hot Sheet
Price: $16.97 +0.30%
Rating Summary:
4 Buy, 10 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
4 Buy, 10 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
BofA Securities analyst Tazeen Ahmad lowered the price target on Theravance Biopharma (NASDAQ: TBPH) to $10.00 (from $11.00) while maintaining a Underperform rating.
You May Also Be Interested In
- Fiserv (FISV) PT Lowered to $60 at Freedom Broker
- Diversified Royalty Corp (DIV:CN) (BEVFF) PT Lowered to Cdn$4.75 at Desjardins
- Solar Industries (SOIL:IN) PT Raised to INR23,500 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
